1 – 10 of 18
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2021
- 
                        Mark
        Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Oral Contraceptive Use and Breast Cancer Risk : Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
    
    - Contribution to journal › Article
 
- 2017
- 
                        Mark
        Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
    
    - Contribution to journal › Article
 
- 2015
- 
                        Mark
        An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
    
    - Contribution to journal › Article
 
- 2014
- 
                        Mark
        DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    
    - Contribution to journal › Article
 
- 2012
- 
                        Mark
        Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
    
    - Contribution to journal › Article
 
- 
                        Mark
        A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers
    
    - Contribution to journal › Article
 
- 
                        Mark
        Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    
    - Contribution to journal › Article
 
